Compounds > uftoral
Page last updated: 2024-08-26

uftoral and Neoplasms

uftoral has been researched along with Neoplasms in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (87.50)18.2507
2000's1 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taguchi, T3
Pazdur, R2
Benner, SE; Canetta, R; Hoff, PM; Pazdur, R1
Benner, S; DeMario, MD; Fleming, GF; Johnson, S; Lebwohl, D; Mani, S; Melton, K; Ratain, MJ; Vogelzang, NJ; Vokes, EE1
de Bono, JS; Twelves, CJ1

Reviews

5 review(s) available for uftoral and Neoplasms

ArticleYear
Modulation of 5-FU and its related compounds.
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24 Suppl 1

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Fluorouracil; Humans; Neoplasms; Pyridines; Tegafur; Uracil

1997
Experience with UFT in Japan.
    Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:9 Suppl 10

    Topics: Chemotherapy, Adjuvant; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Combinations; Humans; Japan; Neoplasms; Tegafur; Treatment Outcome; Uracil

1997
UFT: biochemical modulation for 5-fluorouracil (5-FU).
    Chinese medical journal, 1997, Volume: 110, Issue:4

    Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Drug Combinations; Fluorouracil; Humans; Lung Neoplasms; Neoplasms; Tegafur; Uracil

1997
UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
    Anti-cancer drugs, 1998, Volume: 9, Issue:6

    Topics: Administration, Oral; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Drug Combinations; Humans; Leucovorin; Lung Neoplasms; Neoplasms; Stomach Neoplasms; Tegafur; Uracil

1998
The oral fluorinated pyrimidines.
    Investigational new drugs, 2001, Volume: 19, Issue:1

    Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Biological Availability; Biotransformation; Capecitabine; Clinical Trials as Topic; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Enzyme Inhibitors; Fluorouracil; Humans; Neoplasms; Oxidoreductases; Prodrugs; Tegafur; Uracil

2001

Trials

2 trial(s) available for uftoral and Neoplasms

ArticleYear
Phase I and pharmacokinetic evaluations of UFT plus oral leucovorin.
    Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:9 Suppl 10

    Topics: Administration, Oral; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Drug Combinations; Fluorouracil; Humans; Leucovorin; Neoplasms; Tegafur; Tetrahydrofolates; Uracil

1997
A phase I study of oral uracil/ftorafur (UFT) plus leucovorin and bis-acetato-ammine-dichloro-cyclohexylamine-platinum IV (JM-216) each given over 14 days every 28 days.
    Cancer chemotherapy and pharmacology, 1999, Volume: 43, Issue:5

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Humans; Leucovorin; Neoplasms; Organoplatinum Compounds; Tegafur; Treatment Outcome; Uracil; Vomiting

1999

Other Studies

1 other study(ies) available for uftoral and Neoplasms

ArticleYear
UFT: East meets West in drug development.
    Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:9 Suppl 10

    Topics: Administration, Oral; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Drug Therapy, Combination; Humans; Japan; Leucovorin; Neoplasms; Tegafur; United States; Uracil

1997